Australia markets closed

Eli Lilly and Company (0Q1G.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
540.00+295.04 (+120.45%)
As of 04:18PM BST. Market open.
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 30.00%
S&P500 52-week change 322.43%
52-week high 3540.00
52-week low 30.00
50-day moving average 3540.00
200-day moving average 3540.00

Share statistics

Avg vol (3-month) 35k
Avg vol (10-day) 35k
Shares outstanding 51.01B
Implied shares outstanding 6N/A
Float 8898.08M
% held by insiders 10.16%
% held by institutions 184.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 34.69
Trailing annual dividend yield 31.91%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 17.08%
Operating margin (ttm)31.20%

Management effectiveness

Return on assets (ttm)12.60%
Return on equity (ttm)50.75%

Income statement

Revenue (ttm)35.93B
Revenue per share (ttm)39.92
Quarterly revenue growth (yoy)26.00%
Gross profit (ttm)N/A
EBITDA 13.37B
Net income avi to common (ttm)6.14B
Diluted EPS (ttm)6.52
Quarterly earnings growth (yoy)66.80%

Balance sheet

Total cash (mrq)2.65B
Total cash per share (mrq)2.95
Total debt (mrq)26.35B
Total debt/equity (mrq)204.28%
Current ratio (mrq)1.35
Book value per share (mrq)14.23

Cash flow statement

Operating cash flow (ttm)3.68B
Levered free cash flow (ttm)-1.23B